Gene Solutions | Diagnosing Parkinsons Disease | Parkinson’s Drug Discovery | Parkinson’s Drug Target | Parkinson’s Gene

Corporate Vision
Leverage our discovery platform to facilitate discovery and development of novel molecular genetic targets that will enable effective diagnosis and treatment of major neurologic diseases such as Parkinson’s disease. Build upon our cutting-edge gene research to advance the applications of our technology into the diagnosis and treatment of other important and devastating diseases affecting large segments of the population.

Technology Overview
Gene Solutions represents a breakthrough diagnostic and therapeutic approach to Central Nervous System disease indications utilizing mitochondrial genomics to identify disease-causing mitochondrial mutations. These mutations, which have been validated as highly indicative in Parkinson’s Disease, will form the basis of Gene Solutions diagnostics and therapeutic development platforms. Gene Solutions intends to continue its research to identify similar mitochondrial mutations that are present in, and potentially causative of, other neurologic conditions. Gene Solutions is seeking partnerships with pharmaceutical and biotechnology companies to bring novel and vital cures to large segments of our aging population based on this genetic approach to neurological disease treatment.

Recent News
December 17, 2009
Gene Solutions, LLC executes License Option agreement for Parkinson’s Disease Diagnostic Markers with Transgenomic, Inc.
Read more.

June 5, 2009
Gene Solutions, LLC is issued U.S. Patent No. 7,537,893, the company’s first U.S. patent covering its proprietary genetic mutations, and associated method patents for developing Parkinsons Disease molecular diagnostics and therapeutics.
Read more.